Literature DB >> 16117723

Augmentation of endothelial function following exercise training is associated with increased L-arginine transport in human heart failure.

Melinda M Parnell1, Diane P Holst, David M Kaye.   

Abstract

We have reported previously a decrease in the clearance of the NO (nitric oxide) precursor L-arginine in the forearm circulation of CHF (congestive heart failure) patients, suggesting a potential rate-limiting mechanism contributing to the common finding of endothelial dysfunction in CHF. Given data that show exercise training augments endothelial function in CHF, the aim of the present study was to investigate whether these improvements were due to an increase in L-arginine transport. Measures of L-arginine transport, endothelial function and exercise capacity were repeated before and after 8 weeks of "usual living" or exercise training in 21 CHF patients [NYHA (New York Heart Association) class II/III]. Exercise capacity (6-min walk test) increased following exercise training (496+/-21 to 561+/-17 m; P=0.005), whereas the control group demonstrated no change [488+/-18 to 484+/-21 m; P=ns (not significant)]. Basal FBF (forearm blood flow) remained stable following exercise training (2.68+/-0.55 to 2.46+/-0.32 ml.min(-1).100 ml(-1) of tissue) and "usual living" (2.16+/-0.37 to 2.91+/-0.55 min(-1).100 ml(-1) of tissue). FBF responses to ACh (acetylcholine) increased following exercise by 49.6+/-17.7% (area under curve; P=0.01) demonstrating augmented endothelial function. FBF responses to SNP (sodium nitroprusside) were also improved following exercise training (30.8+/-8.2%; P=0.02). There was no change in vascular function in the "usual living" group. The clearance of L-arginine was significantly increased following involvement in the exercise programme (69.4+/-7.8 to 101.0+/-9.5 ml/min; P=0.04), whereas there was no change in the "usual living" group (78.4+/-17.5 to 81.0+/-14.9 ml/min; P=ns). In conclusion, the augmentation in endothelial function observed following exercise may be due, in part, to an increase in the transport of L-arginine in CHF patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16117723     DOI: 10.1042/CS20050171

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

Review 1.  Exercise and heart failure in the elderly.

Authors:  Tissa Kappagoda; Ezra A Amsterdam
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Voluntary wheel running augments aortic l-arginine transport and endothelial function in rats with chronic kidney disease.

Authors:  Christopher R Martens; James M Kuczmarski; Jahyun Kim; John J Guers; M Brennan Harris; Shannon Lennon-Edwards; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

Review 3.  Impact of inactivity and exercise on the vasculature in humans.

Authors:  Dick H J Thijssen; Andrew J Maiorana; Gerry O'Driscoll; Nigel T Cable; Maria T E Hopman; Daniel J Green
Journal:  Eur J Appl Physiol       Date:  2009-11-27       Impact factor: 3.078

Review 4.  Effects of exercise interventions on peripheral vascular endothelial vasoreactivity in patients with heart failure with reduced ejection fraction.

Authors:  Karen M Vuckovic; Mariann R Piano; Shane A Phillips
Journal:  Heart Lung Circ       Date:  2013-01-20       Impact factor: 2.975

Review 5.  The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise.

Authors:  Christopher R Martens; Danielle L Kirkman; David G Edwards
Journal:  Exerc Sport Sci Rev       Date:  2016-01       Impact factor: 6.230

6.  Nitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances.

Authors:  Noboru Toda; Shinichi Tanabe; Sadanobu Nakanishi
Journal:  Int J Angiol       Date:  2011-09

7.  The role of exercise on L-arginine nitric oxide pathway in chronic heart failure.

Authors:  A C Mendes-Ribeiro; G E Mann; L R de Meirelles; M B Moss; C Matsuura; T M C Brunini
Journal:  Open Biochem J       Date:  2009-10-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.